Hisashi Nishiwaki Selected Research

uvedafolin

12/2015

New Sesquiterpene Lactone Dimer, Uvedafolin, Extracted from Eight Yacon Leaf Varieties (Smallanthus sonchifolius): Cytotoxicity in HeLa, HL-60, and Murine B16-F10 Melanoma Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisashi Nishiwaki Research Topics

Disease

3	Hypersensitivity (Allergy) 11/2019 - 01/2014
1	Inflammation (Inflammations) 08/2021
1	Neoplasms (Cancer) 11/2019
1	Leukemia 11/2019
1	Seasonal Allergic Rhinitis (Hay Fever) 11/2019
1	Obesity 01/2019
1	Infections 08/2017
1	Melanoma (Melanoma, Malignant) 12/2015
1	Diabetes Mellitus 01/2014
1	Hemolysis 05/2007

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 08/2021 - 11/2019
2	Dehydroepiandrosterone (DHEA)IBA 11/2019 - 11/2019
1	Interleukin-10 (Interleukin 10)IBA 08/2021
1	p38 Mitogen-Activated Protein KinasesIBA 08/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	LipopolysaccharidesIBA 08/2021
1	Anti-Allergic Agents (Antiallergic Agents)IBA 11/2019
1	ficifolidioneIBA 11/2019
1	Immunoglobulin E (IgE)IBA 11/2019
1	LipidsIBA 01/2019
1	PhytochemicalsIBA 01/2019
1	LignansIBA 08/2017
1	SesquiterpenesIBA 12/2015
1	uvedafolinIBA 12/2015
1	LactonesIBA 12/2015
1	Rosmarinic AcidIBA 01/2014
1	Hexosaminidases (Hexosaminidase)IBA 01/2014
1	GlucosidasesIBA 01/2014
1	Protein SIBA 05/2007

Therapy/Procedure

1	Oral Administration 08/2021